Compound 13 | Compound 21 | ||
---|---|---|---|
Absorption | Caco2 permeability | 0.823 | 1.035 |
Intestinal absorption (human) | 91.939 | 86.102 | |
Skin Permeability | − 2.738 | − 2.735 | |
Distribution | Volume of distributions | 1.411 | 0.932 |
Fraction unbound (human) | 0.183 | 0.082 | |
BBB permeability | − 0.024 | − 0.001 | |
CNS permeability | − 2.192 | − 2.168 | |
Metabolism | CYP2D6 substrate | Yes | Yes |
CYP3A4 substrate | Yes | Yes | |
Excretion | Total Clearance | 0.623 | 0.906 |
Renal OCT2 substrate | Yes | Yes | |
Toxicity | AMES toxicity | Yes | Yes |
Oral rat acute toxicity (LD50) | 2.919 | 2.723 | |
Minnow toxicity | − 0.674 | 0.257 |